Neuestes

Swiss Re: AI and energy capex could add $200bn industrial insurance premiums by 2030
Swiss Re Institute says the global capex supercycle in data centers and power infrastructure could generate $200bn in premiums from 2026 to 2030 while increasing risk concentration.

Swiss Life Reports Strong First-Half 2026 Results, Fee Growth and Cost Cuts Ahead
Swiss Life Holding AG reported a 8% increase in net profit and fee revenue in the first half of 2026, while outlining plans to cut 600 jobs by year-end 2028.

Partners Group reports H1 results; Layton steps down as CEO
Management income rises 6% to CHF 905m as AuM reaches USD 186bn; Co-CEOs Cagnati and Jenkner appointed effective January 2027.

European bond yields rise, ending two‑day rally ahead of ECB meeting
German 10‑year Bund yields nudged up to around 3.36% as markets priced in a 25‑bp ECB rate hike, while euro‑zone inflation hit 3.3% in August and oil prices stayed above $90 a barrel.

Swiss SMI slides over 1%, LVMH hits six‑year low, ABB leads gains
The Swiss market index fell to 14,221 as LVMH reached its lowest level since 2018, while ABB posted the biggest rise; USD/CHF slipped to 80.89 Rappen and US exchanges stayed closed for a holiday.

Swiss equities slip as US markets close, Novartis drags index lower; USD/CHF falls
The SMI fell 1.2% to 14,221 points after Novartis lost 3.3% on a failed drug trial, while the franc edged higher to 80.89 per dollar and USD/JPY slipped to 154.07 yen.

Swiss market slides as Novartis falls on failed drug trial, dollar weakens against franc
The SMI dropped over 1% to 14,221 points, led by a 3% slide in Novartis after negative Pelacarsen news, while the U.S. dollar fell to 80.89 rappen.

DAX slips below 26,000 points as rate outlook and oil prices tighten
The German benchmark index fell 0.37% to 25,951, breaking the 26,000 level amid ECB rate‑hike expectations, US inflation data and Brent crude trading above $97.

Swiss SMI slides over 1% as Novartis tumbles on failed drug trial
SMI fell 1.2% to 14,221 points, led by a 4.2% drop in Novartis after its Pelacarsen trial missed; other health‑care stocks and Schindler also fell, while Kühne+Nagel and ABB posted modest gains.

FINMA director stresses proportional oversight for Swiss banks
FINMA says supervision intensity follows size, complexity and risk, not a blanket approach on small banks, citing inspection frequency and the 2020 Kleinbankenregime.

DAX slips below 26,000 as oil prices stay high and markets await ECB decision
The German benchmark index fell 0.24% to 25,983 points, while the MDAX rose 0.23% to 32,429. Brent crude hovered just under $97 a barrel and the ECB is set to raise rates to 2.5% on Thursday.

Swiss equities slip as Roche, Novartis drag; ABB gains, yen hits 7‑month high
The SMI fell about 1% to 14,221 points, led by 3%‑plus losses in Novartis and Roche after a failed Pelacarsen trial. ABB rose, while the yen strengthened to 154.07 per dollar, its lowest level in seven months.

Germany to Deploy Anti‑Sabotage Shield After Failed Drone Attack
Interior Minister Alexander Dobrindt announced a package of police, cyber and AI measures to protect airports, transport hubs and critical infrastructure from drone and sabotage threats.

Europe's sovereign yields diverge as France and Germany face higher deficits
Ten‑year bond yields in France and Germany are nearing 2007 highs, while Spain and Italy remain below 2023 peaks, reflecting differing fiscal outlooks across the euro area.

Swiss SMI edges up 0.2% as Logitech and Roche lead gains, Richemont and Nestlé fall
The Swiss Market Index closed at 14,394 points, up 0.22%, driven by Logitech (+3.3%) and Roche (+2.1%). Luxury stocks lagged, while US software shares surged on Snowflake’s outlook.

Swiss stocks rise as Roche leads; Richemont falls on luxury sector weakness
Swiss Market Index edges up 0.12% as Roche gains on licensing deal, while Richemont drops 2.4% amid broader luxury sector decline. Swiss franc strengthens to 0.9384 per euro after August inflation surprise.

Swiss franc strengthens after higher-than-expected Swiss inflation data
The Swiss franc surged after August inflation rose to a two-year high, while the euro and dollar weakened. Analysts see potential SNB tightening in December, though energy-driven price gains may limit immediate action.

US stocks rise on Fed rate pause hopes; Swiss franc strengthens
Wall Street advances as investors bet on a September Fed pause, while the Swiss franc gains after higher-than-expected Swiss inflation. SMI mixed as Nestlé weighs on index.

Zumtobel Q1 FY2026/27 margins rise on cost cuts despite flat revenue
Austrian lighting group Zumtobel posted a 25% rise in adjusted EBIT to €8.2 million in Q1 FY2026/27, even as revenue slipped 0.9% to €264.1 million. Guidance maintained for flat annual sales.

Swiss stocks rise on US gains; Nestlé, Richemont drag; franc strengthens
Swiss Market Index edges up 0.2% after early 0.5% gain as Nestlé drags; Roche and Logitech lead gains. Euro falls to 0.9384 francs as Swiss inflation surprises.

US stocks rise on softer yields; Swiss franc strengthens after inflation surprise
U.S. benchmarks advance 0.4-0.6% at open as Treasury yields ease; SMI up 0.5% led by Roche and Logitech. Swiss inflation hits two-year high, lifting franc to 0.9392 per euro.

UBS identifies four European investment themes as earnings rebound gains traction
Strategists flag industrials, banks, quality leaders and Swiss mid-caps as Europe’s earnings cycle shifts from stagnation to growth, with 15% EPS growth forecast for 2026.

US stocks set for modest gain; SMI rises on Roche, Logitech gains; Swiss franc strengthens
U.S. futures point to a modestly higher open as Middle East tensions ease slightly. Swiss Market Index climbs 0.2% on Roche and Logitech gains, while the franc strengthens after Swiss inflation surprises.

US stocks cautious as oil prices rise; Swiss franc strengthens on inflation data
Dow Jones and Nasdaq futures show muted gains ahead of key U.S. jobs data, while rising oil prices and geopolitical tensions curb risk appetite. Swiss franc surges to 0.9392 per euro after unexpected inflation jump.

